Photo: Elaine Thompson / AP

The first nine months of 2017 are the second-warmest in records that date back to the late 1800s, according to the latest monthly National Oceanic and Atmospheric Administration report Wednesday.

Why it matters: The data underscore how this year is part of a long-term warming trend that scientists say is largely due to human influences.

The gritty details: The January-September period was 0.87°C (1.57°F) above the 20th-century average.

  • "Nine of the 10 warmest January-September global land and ocean temperatures occurred during the 21st century (since 2005), with only one year from the 20th century (1998) among the top 10. Based on three simple scenarios, 2017 will likely end up among the top three warmest years on record," NOAA said.

Go deeper

Updated 48 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.